AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI ...

Across health and life sciences, artificial intelligence is elevating patient care and accelerating drug discovery, driving a powerful wave of innovation. With its deep industry strengths and growing ...

Anthropic has acquired AI biotech startup Coefficient Bio for roughly $400 million, according to a person with knowledge of ...

Imagine an official in India facing a public health crisis, say a new variant of the often-deadly Nipah virus cropping up in clinics. A new vaccine could help to contain the outbreak, but developing ...

Anthropic has acquired Coefficient Bio, a stealth biotech startup with fewer than 10 people, for $400 million in stock. The ...

The move positions Anthropic in a $100B+ drug discovery market that’s ripe for disruption, blending frontier models with ...

Science is entering a massive publishing boom, in large part due to artificial intelligence. New research published in the journal Science has revealed that scientists who use large language models ...

On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence Adrian Woolfson Bloomsbury (2026) Biology is undergoing a transformation. After centuries of studying life as it ...

A study released by Google Cloud late last year offered some eye-opening insights into where life sciences and healthcare executives are using artificial intelligence (AI), where they are not, and ...

Generative AI (GenAI) has entered the life sciences mainstream. Pharmaceutical, biotech and medical device organizations are already testing it across regulatory documentation, quality processes, ...